AKAlan Taylor Kelley

Alan Taylor Kelley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan Taylor Kelley has a total of 136 co-authors. Here are the top co-authors by number of shared publications:

  • Adam J. Gordon

    Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

    10 shared publications
  • Audrey L. Jones

    Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah USA

    7 shared publications
  • Gerald Cochran

    Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), University of Utah School of Medicine, Salt Lake City, UT, USA

    4 shared publications
  • Jacob D. Baylis

    Department of Population Health Sciences University of Utah School of Medicine Salt Lake City Utah USA

    4 shared publications
  • Michael A. Incze

    Division of General Internal Medicine, Department of Internal Medicine, University of Utah, Salt Lake City

    4 shared publications
  • Jacob D. Baylis

    Informatics, Decision-Enhancement and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, USA

    3 shared publications

Latest Publications

  • Open Access

    Primary care provider attitudes regarding physical therapists addressing opioid use and opioid misuse: a qualitative study

    by John S Magel, Elizabeth Siantz, Michael A Incze, Jason M Beneciuk, Julie M Fritz, A Taylor Kelley, Gerald Cochran, Priscilla Blosser, Paul Hartman, Melissa Tyszko, et al.

    Importance: Primary care providers (PCPs) manage musculoskeletal pain and may prescribe opioids for their patients, presenting risk for opioid misuse. Physical therapists are well-positioned to collaborate with PCPs in identifying and mitigating opioid risk and misuse for patients that PCPs and physical therapists co-manage. How PCPs view such collaboration is unclear. Objective: The objective of this study was to explore PCPs’ attitudes regarding physical therapists’ role in identifying and mitigating opioid risk and opioid misuse. Design: This was a qualitative study using rapid content analysis and it was the first phase in a sequential exploratory mixed-methods investigation. Setting and participants: Semi-structured interviews were conducted with 22 PCPs in Utah. PCPs were invited to participate if they were listed by the Utah Division of Professional Licensure as having an active license to practice in Utah. PCPs were eligible to participate if they (1) referred a patient to outpatient physical therapy within the past 6 months and (2) prescribed an opioid within the past 6 months. Interviews were conducted between May 6, 2024, and August 9, 2024, and were audio recorded and transcribed. Main Outcome: The main outcomes were qualitative themes reported by the PCPs surrounding their attitudes toward collaborating with physical therapists on patients taking prescription opioid medication for pain. Results: Twenty-two PCPs were interviewed, which included 7 (31.8%) physicians, 6 (27.3%) nurse practitioners, and 9 (40.9%) physician assistants. Mean years of clinical experience was 13.9 (SD = 9.1) with 12 (56.0%) participants identifying as female and 20 (90.1%) identifying as White. The themes identified were (1) physical therapist’s involvement in opioid management can help patients, (2) communication between physical therapists and PCPs regarding opioids is important, (3) physical therapists should educate their patients about the risks of opioid use, and (4) physical therapists should refer their patients with suspected opioid misuse for further management. Conclusion and relevance: PCPs favorably regarded physical therapists’ involvement in identifying and mitigating opioid risk and misuse among co-managed patients.

  • Factors associated with mortality following hospitalization among veterans with opioid use disorder

    by Michael A. Incze, Sophia Huebler, Jacob D. Baylis, Andrea Stofko, A. Taylor Kelley, Ingrid A. Binswanger, Gavin Bart, Andrew J. Saxon, Ajay Manhapra, Adam J. Gordon


  • Changes in healthcare utilization and costs following enrollment in an interprofessional primary care clinic designed to address clinical and social vulnerabilities

    by A. Taylor Kelley, Minkyoung Yoo, Ying Suo, Richard E. Nelson, Adam J. Gordon, Audrey L. Jones

    Meeting the needs of patients with substance use disorders (SUDs), complex comorbidity, and social determinants of poor health is challenging in traditional primary care environments. Interprofessional primary care (IPC) can better address these needs and may reduce acute care utilization and healthcare costs. We used a retrospective cohort study design (n = 994 patients) to compare healthcare utilization and costs 2 years before and after patients enrolled in an IPC model in the US Veterans Health Administration. Patients were grouped based on histories of high emergency department (ED) use, SUDs, homelessness, and combinations of these vulnerabilities. Generalized estimating equations (GEE) tested for differences in utilization and costs across groups. Following IPC enrollment, primary care visits and costs increased overall (adjusted increase = 2.90-7.24 visits/person-year; $1,032-$2,817/person-year). Among patients with prior high ED use, acute care costs declined; among patients without prior high ED use, acute care costs were mixed and ED use increased. Total costs decreased, were neutral, and increased for patients with 3, 1-2, and no vulnerabilities, respectively. Primary care engagement, reduced acute care, and limited cost increases suggest high value in this IPC model and highlight the need to further study IPC in addressing addiction and social determinants of poor health.


  • A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results

    by Kody Hafen, Harlan Wallace, Kayla Fritz, Cole Fordham, Tyler Haskell, A. Taylor Kelley, Audrey L. Jones, Gerald Cochran, Adam J. Gordon

    Background: Rural and frontier communities face high rates of opioid use disorders (OUDs). In 2021, the Rural Addiction Implementation Network (RAIN) sought to establish a rural hospital/clinic-system practice-based research network (RH-PBRN) to facilitate implementation of evidence-based addiction-related prevention, treatment, and recovery (PTR) services to reduce the morbidity of OUD and substance use disorder (SUD) in rural communities.Objective: To describe the goals and implementation of PTR activities of RAIN, a novel RH-PBRN.Methods: RAIN identified teams of external/internal facilitators at four rural hospitals/clinic-networks to achieve at least 15 PTR activities involving OUD and other SUDs. RAIN utilized an implementation-facilitation approach: facilitators assessed the implementation environment and promoted interventions to overcome barriers to PTR implementation. Other interventions included site visits, community of learning calls, and e-communication. RAIN assessed and recorded facilitators and barriers to implementation, milestone attainment, and outcomes of PTR activities. At 18 months, we queried facilitators about the fidelity and implementation of RAIN activities.Results: RAIN established an HP-PBRN in four sites (Idaho, Montana, Utah, and Wyoming). Within the HP-PBRN, 20 PTR activities were established (p = 7, T = 10, R = 3; range 3-7 per site). Barriers to implementation of PTR activities included competing clinical demands, especially due to COVID-19, lack of dedicated effort for staff at sites, and stigma of addiction and its treatment. Facilitators of implementation included the use of trained expert facilitators and communication between the sites.Conclusions: RAIN implemented 20 addiction-related PTR activities in four rural hospitals/clinic-networks. RAIN's intervention model could be replicated to address addiction-related harms in other rural communities.

  • Trends in Bundled Outpatient Behavioral Health Services in VA-Direct Versus VA-Purchased Care

    by A. Taylor Kelley, Michael P. Torre, Todd H. Wagner, Amy K. Rosen, Michael Shwartz, Chao-Chin Lu, Todd K. Brown, Tianyu Zheng, Erin Beilstein-Wedel, Megan E. Vanneman

    The Veterans Health Administration (VA) increasingly purchases community-based care (CC) to improve healthcare access, including behavioral health. In 2018, VA introduced standardized episodes of care (SEOCs) to guide authorization and purchase of CC services for specific indications in a defined timeframe without bundling payment. In this retrospective cross-sectional study, we describe trends in VA and CC behavioral healthcare utilization using the VA Outpatient Psychiatry SEOC definition. Counts of Outpatient Psychiatry SEOC-allowable service and procedure codes during fiscal years 2016–2019 were organized according to four SEOC-defined service types (evaluation and management, laboratory services, psychiatry services, transitional care) and measured as percentages of all included codes. Trends comparing behavioral healthcare utilization between Veterans using any CC versus VA only were analyzed using a linear mixed effects model. We identified nearly 3 million Veterans who registered 60 million qualifying service and procedure codes, with overall utilization increasing 77.8% in CC versus 5.2% in VA. Veterans receiving any CC comprised 3.9% of the cohort and 4.7% of all utilization. When examining service type as a percent of all Outpatient Psychiatry SEOC-allowable care among Veterans using CC, psychiatry services increased 12.2%, while transitional care decreased 8.8%. In regression analysis, shifts in service type utilization reflected descriptive results but with attenuated effect sizes. In sum, Outpatient Psychiatry SEOC-allowable service utilization grew, and service type composition changed, significantly more in CC than in VA. The role of SEOCs and their incentives may be important when evaluating future behavioral healthcare quality and value in bundled services.


  • Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders

    by A. Taylor Kelley, Michael A. Incze, Michael Baumgartner, Aimee N.C. Campbell, Edward V. Nunes, Daniel O. Scharfstein


  • Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders

    by Annette Percy, A. Taylor Kelley, Natalie Valentino, Amy Butz, Jacob D. Baylis, Ying Suo, Adam J. Gordon, Audrey L. Jones

    Background: Clinical pharmacist practitioners (CPPs) play an increasingly important role in interdisciplinary care for patients with substance use disorders (SUDs). However, CPPs’ scope of practice varies substantially across clinics and settings. Objectives: We sought to describe CPP practices and activities within an interdisciplinary, team-based primary care clinic dedicated to treat Veterans with histories of substance use disorders, experience of homelessness, high medical complexity, and other vulnerabilities. Methods: We conducted a retrospective cohort study of CPP activities using Department of Veterans Affairs (VA) administrative data in 2019. Results: CPPs provided care for 228 patients, including 766 in-clinic visits, 341 telephone visits, and 626 chart reviews, with an average of 2.5 hours spent per patient per year. Patients seen by CPPs frequently experience mental health conditions and SUDs, including depression (66%), post-traumatic stress disorder (52%), opioid use disorder (OUD) (45%), and alcohol use disorder (44%). CPPs managed buprenorphine medications for OUD or chronic pain in 76 patients (33%). Most CPP interventions (3330 total) were for SUDs (33%), mental health conditions (24%), and pain management (24%), with SUD interventions including medication initiation, dose changes, discontinuations and monitoring. As part of opioid risk mitigation efforts, CPPs queried the state’s prescription drug monitoring program 769 times and ordered 59 naloxone kits and 661 lab panels for empaneled patients. Conclusion: CPPs managed a high volume of vulnerable patients and provided complex care within an interdisciplinary primary care team. Similar CPP roles could be implemented in other primary care settings to increase access to SUD treatment.


  • Open Access

    Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives

    by A. Taylor Kelley, Jordynn Wilcox, Jacob D. Baylis, Norah L. Crossnohere, John Magel, Audrey L. Jones, Adam J. Gordon, John F. P. Bridges

    Background Primary care providers (PCPs) are essential to increasing access to office-based buprenorphine medication treatment for opioid use disorder (B-MOUD). Barriers to B-MOUD prescribing are well-documented, but there is little information regarding incentives to overcome these barriers. Objective To identify optimal incentives for PCPs to promote B-MOUD prescribing and compare incentive preferences across provider and practice characteristics. Design We surveyed PCPs using best-worst scaling (BWS) to prioritize seven potential incentives for B-MOUD prescribing (monetary compensation, paid vacation, protected time, professional development, reduced workload, service recognition, clinical resources). We then used a direct elicitation approach to determine preferred incentive levels (e.g., monetary thresholds) and types (e.g., specific clinical resources). Participants Primary care physicians and advanced practice providers (APPs) at a large Department of Veterans Affairs healthcare system. Main Measures B-MOUD prescribing incentive preferences and relative preference levels using descriptive statistics and conditional logistic regression with relative importance scale transformation (coefficients sum to 100, higher coefficient=greater importance). Key Results Fifty-three PCPs responded (73% response), including 47% APPs and 36% from community-based clinics. Reduced workload (relative importance score=26.8), protected time (18.7), and clinical resources (16.8) were significantly more preferred (Ps < 0.001) than professional development (10.5), paid vacation (10.3), or service recognition (1.5). Relative importance of monetary compensation varied between physicians (12.6) and APPs (17.5) and between PCPs located at a medical center (11.4) versus community clinic (22.3). APPs were more responsive than physicians to compensation increases of $5000 and $12,000 but less responsive to $25,000; trends were similar for medical center versus community clinic PCPs. The most frequently requested clinical resource was on-demand consult access to an addiction specialist. Conclusions Interventions promoting workload reductions, protected time, and clinical resources could increase access to B-MOUD in primary care. Monetary incentives may be additionally needed to improve B-MOUD prescribing among APPs and within community clinics.


  • Open Access

    Directly Observed Care: Crossing the Chasm of Quality Measurement

    by A. Taylor Kelley, Saul J. Weiner, Joseph Francis

    After more than two decades of national attention to quality improvement in US healthcare, significant gaps in quality remain. A fundamental problem is that current approaches to measure quality are indirect and therefore imprecise, focusing on clinical documentation of care rather than the actual delivery of care. The National Academy of Medicine (NAM) has identified six domains of quality that are essential to address to improve quality: patient-centeredness, equity, timeliness, efficiency, effectiveness, and safety. In this perspective, we describe how directly observed care—a recorded audit of clinical care delivery—may address problems with current quality measurement, providing a more holistic assessment of healthcare delivery. We further show how directly observed care has the potential to improve each NAM domain of quality.